Aspirin in diabetic patients at primary prevention: insights of the VITAL cohort
ConclusionsThe VITAL data confirmed diabetes as an important risk factor for cardiovascular events in a contemporary cohort but did not show cardiovascular benefits of aspirin in primary prevention among people with diabetes who were shown to be at higher risk of cardiovascular events.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Cholesterol | Coronary Heart Disease | Diabetes | Endocrinology | Heart | Heart Disease | Smokers | Statin Therapy | Stroke